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Photochemical ‘In-Air’ Combinatorial Discovery of Antimicrobial 
Copolymers   
Sarah-Jane Richards,[a] Adam Jones[a] Ruben M.F. Tomás[a] and Matthew I. Gibson*[a] 
Abstract: There is an urgent need to identify new, non-traditional 
antimicrobials. The discovery of new polymeric antimicrobials is 
limited by current low-throughout synthetic tools meaning limited 
chemical space is explored. Here we employ photo-chemical ‘in-air’ 
RAFT polymerization with microwell plates, using liquid handling 
robots to assemble large libraries of cationic polymers, without the 
need for degassing or purification steps, facilitating transfer to 
screening. Several lead polymers are identified including a copolymer 
with propylene glycol side chains with significantly enhanced 
antimicrobial activity, and increased therapeutic window. Mechanistic 
studies showed this polymer was bacteriostatic and surprisingly did 
not lyse the cell membranes, implying an alternative mode of action. 
This versatile method, using simple robotics, will help develop new 
biomaterials with emergent properties. 
Combinatorial methods are widely employed in small-molecule 
chemistry to identify previously unknown leads against well-
characterized targets, and includes concepts such as fragment-
based design.1,2 Commercial compound libraries are available 
with >5000 members and repurposing of known drugs is 
underpinned by screening.3 In the discovery of polymer 
biomaterials, there are the additional variables of monomer, 
molecular weight, and architecture. This provides vast chemical 
space to be explored, presenting a challenge and opportunity.4 
Polymers for gene delivery have been successfully identified 
using combinatorial condensation polymerization5,6 but there was 
molecular weight heterogeneity. Alexander, Langer and Anderson 
have developed automated high-throughput screens for polymer 
surfaces enabling discovery of polymer surfaces for resisting 
bacterial attachment7 or the culture of stem cells.8 However, for 
soluble polymers intended to interface with cells/proteins, well-
defined materials are required with control of MW to enable 
selection and tuning of the final properties.9,10 Controlled radical 
(CRP) or ionic polymerization requires inert atmospheres and 
sealed vials, and in the case of ionic polymerizations rigorously 
anhydrous conditions, adding complexity and time due to 
processing. Schubert and Hoogenboom have used automated 
synthesizers for polymerizations, but such protocols require a 
precipitation/isolation step limiting the potential of the libraries.4,11 
To truly use combinatorial polymer methods to discover ‘drug-like’ 
materials the synthetic and handling methods should be 
compatible with the industry standard, 96-, 384- and 1536-well 
plates used in biomedical screening with liquid handling 
robotics.12  
To address the combinatorial challenge, air tolerant CRP 
methods are emerging. Chapman et al. used glucose oxidase for 
in situ degassing in 96-well plate format RAFT polymerizations13 
and this approach has also been applied to ATRP formualtions.14 
Light mediated polymerizations15 enable the trapping/removal of 
oxygen species using organic16 and inorganic17 photo-redox 
catalysts. Trithiocarbonates can also be used as intrinsic 
photoredox catalysts in RAFT, without the need for supplemental 
catalysts which is appealing for biomedical screening.18 Recently, 
Boyer and co-workers used photo-RAFT in 96-well plates to 
screen star polymers for binding to a model lectin, facilitating the 
design of new binders.19 However, there are limited examples of 
application to urgent biomedical materials screening challenges, 
such as new antimicrobials to combat resistance.20 Cationic 
polymers have been employed as antimicrobial agents, inspired 
by antimicrobial peptides21 with broad spectrum activity and slow 
emerging resistance.22 The most active antimicrobial polymers 
are not homopolymers, but require a complex balance of charge 
and hydrophobicity/philicity by incorporation of comonomers.23–26 
Their rational design is typically based on targeting membrane 
lysis, but it is becoming apparent that bacteria aggregation and 
hence interruption of signalling27,28 pore-formation29, DNA 
binding30 and interrupting metabolic processes31 are associated 
with polycations. Structure-function maps, to phenotype (bacteria 
killing), but also to understand mechanism are needed to 
generate data sets to enable ab initio materials design.7  
Here we present combinatorial cationic photo-polymer screening 
for new antimicrobial biomaterials. The intrinsic photo-RAFT 
method18 is adapted to enable automation, scalability and ease of 
use in ‘open’ reaction vessels of a 96 well plate, using liquid 
handling robots, Figure 1A. A photo-RAFT agent 2-cyano-2-
propyl dodecylthiocarbonate is used with a tertiary amine 
(triethanolamine (TEOA)), to degas the solvent (DMSO) enabling 
polymerization to proceed under a blue LED light. 2-
(Dimethylamino)ethyl methacrylate (DMAEMA) was chosen as 
the cationic component based on our previous work showing it 
has potent anti-mycobacterial activity. In this study, there did not 
appear to be a molecular weight effect of the DPs tested (between 
10 and 100) therefore DP 75 was chosen.32,33 Figure 1B and 
Table 1 show results of three parallel DMAEMA polymerizations 
in 96-well plates targeting degrees of polymerization of 25, 50 and 
100. Each achieved >95 % conversation and comparable 
molecular weight distributions confirming reproducible synthesis 
in the small reaction volumes (<200 µL). The procedure was 
validated further by running 60 parallel in-air polymerizations of 
DMAEMA within a single plate. Five wells were then chosen by 
an independent party for SEC analysis, Figure 1C. Comparable 
molecular weights and distributions were obtained, confirming 
precise control over the reaction and homogeneity across all the 
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Figure 1. A) Concept of in-air combinatorial photo-RAFT discovery. B) SEC of 
3 × 3 DP polymerizations of DMAEMA. C) SEC of 5 randomly selected (red 
circles) polymers produced from 60 × DMAEMA polymerizations within a single 
plate. 












C3 100 95 15300 22900 1.66 
C6 50 96 7900 17200 1.57 
C9 25 98 4200 9500 1.33 
E3 100 96 15400 22100 1.63 
E6 50 95 7800 16800 1.60 
E9 25 95 4100 9900 1.37 
G3 100 96 15400 23200 1.61 
G6 50 97 8000 17300 1.49 
G9 25 98 4200 9400 1.33 
aDetermined by 1H NMR against an internal mesitylene standard. bDetermined 
by the [M]:[CTA] ratio and conversion, assuming 100 % CTA efficiency. 
cDetermined by SEC in DMF and reported values are relative to PMMA 
standards.   
 
Traditional polymerization methods are limited in their chemical 
and compositional space meaning the ‘sweet spots’ in copolymer 
libraries can be overlooked. Here, eight comonomers were 
chosen to be copolymerized with DMAEMA, including a mixture 
of hydrophobic and hydrophilic substituents, at four densities (5, 
10, 15, 20 mol%) with three repeats, within 96-well plates to give 
a combinatorial library of 108 distinct polymers in DMSO, Figure 
2 (left column) prepared in a single day. Drug screening is 
routinely conducted in 1 – 5 % DMSO to aid solubilization;34 here 
sampling followed by dilution in appropriate buffer/media resulted 
in [DMSO] < 5 wt %, which controls showed did not affect assays. 
A series of functional screens were undertaken and results 
indicated as a heat map, Figure 2 (green indicates desirable 
outcome, red indicates sample is excluded). To eliminate toxic 
materials, ovine red blood cell haemolysis (Figure 1A) was 
conducted at 1 mg.mL-1. All 108 polymers had haemolysis below 
2 % and no haemagglutination, hence all passed. To screen for 
antimicrobial activity, the resazurin reduction assay (Fig 1A) was 
used which gives a colorimetric output (blue to pink). Escherichia 
coli and Mycobacteria smegmatis were used to represent Gram 
negative and Mycobacteria (which includes M. tuberculosis). The 
MIC99 (minimum concentration to stop growth of 99 % of 
organisms) of homo-PDMAEMA is  250 μg.mL-1 and 31.3 μg.mL-
1 against E. coli and M. smegmatis, respectively.32,33 Copolymers 
were added to the bacteria at 0.5 × MIC99 of PDMAEMA to enable 
selection of copolymers that were at least two-fold more active. 
Against M. smegmatis there were few ‘hits’, potentially due to the 
complex mycobacterial cell walls which are rich in mycolic acids 
and glycans which can ‘shield’ the membrane.32 However, the E. 
coli screen identified several ‘hits’, with copolymers of MMA, iPMA, 
cHMA and PPGMA inhibiting E. coli growth at 0.5 x MIC99 of the 
parent homopolymer.  
These ‘hits’ were tested across a wider concentration range to 
establish their MIC99 (Figure 2, right column). Hydrophobic 
comonomers tended to lower the MIC99. MMA copolymers had a 
sweet spot for activity at 15 wt % with more/less reducing all 
antimicrobial activity. Similarly, iPMA/cHMA copolymers were 
active at 5 and 10 wt % but not at higher incorporation levels. 
Several of the ‘hits’ appeared did not to give lower MIC99 values 
than the homopolymer once tested in full dilution series, justifying 
the hit to lead approach. These observations highlight a key 
benefit of screening to identify non-linear trends that can be 
missed in low-throughput testing. The most active copolymer 
contained 15 wt % poly(propylene glycol)methacrylate (PPGMA) 
with an MIC99 of 15 µg.mL-1, compared to 250 µg.mL-1 for homo-
PDMAEMA. Interestingly, this is not the most hydrophobic 
comonomer (logP values in Supp. Info.) suggesting that a 
membrane insertion/disruption mechanism might not be operating. 
This would not have been predicted based on LogPs alone. 
 
To validate these findings P(DMAEMA(85%)-co-PPGMA(15%)) 
hits were resynthesized to various degrees of polymerization 
(DP30 – 240) to give a panel of ‘pure’, well-defined polymers 
(SEC traces, Figure 3A). Similar MIC99 values were obtained as 
in the initial screen, but the shortest polymers (DP30) were 
identified to be least active, Figure 3B. Membrane integrity assays 
were undertaken to probe the for the greater copolymer activity 
compared to PDMAEMA homopolymer; it is assumed that more 
hydrophobic units promotes insertion into bacterial cell 
membranes, leading to lysis and cell death.24 The assay employs 
a pair of dyes, SYTO 9 (green fluorescence) that enters all cells 
and is associated with intact bacteria and propidium iodide (red 
fluorescence) that can only enter membrane compromised cells 
to probe if membrane lysis has occurred. Figure 3C-H shows 
confocal microscopy images of E. coli incubated under various 
conditions. PDMAEMA at 2 × MIC99 shows only red bacteria, 
consistent with the ‘dead’ control (Figure 3D) and at 0.5 × MIC99 
a mixture of red/green are seen supportive of PDMAEMA 
homopolymers killing E. coli by a lytic mechanism. However, 
P(DMAEMA(85%)-co-PPGMA(15%)) at a concentration above (2 
×) MIC99 gave a mixture of red and green bacteria, showing there 
is less membrane lysis than the PDMAEMA homopolymers even 
though these are more active (lower MIC99). This shows that the 
co-monomer is not simply increasing activity by more membrane 





lysis. Confocal microscopy suggested increased bacterial 
aggregation in response to the copolymer, but not the 
homopolymer. Aggregation is known to modulate bacterial 
responses in their environment, and the copolymers might be 
influencing their colonizing behavior to limit growth via a feedback 
mechanism. 27,35 
  
Figure 2 Library structure, haemolysis at 1 mg.mL-1 and antimicrobial activity 
against E. coli at 125 μg.mL-1 (0.5 × MIC99 of homopolymer (PDMAEMA)). 
To determine if the bacteria were being killed by the copolymers, 
or if their growth were being inhibited, the MBC (minimum 
bactericidal concentration) was determined. For PDMAEMA 
homopolymers the MBC is the same as the MIC99 suggesting 
membrane lysis is the mode of action as would be expected for 
traditional cationic polymers. For the copolymer the MBC actually 
increased to > 1000 μg.mL-1, showing it was less effective at 
killing and lysing bacteria membranes than the homopolymer. 
This suggested that we have identified a mechanism whereby we 
have identified a unique copolymer that inhibits E. coli growth 
potentially due to aggregation, and not physical damage of the 
cell membrane. Bactericidal and bacteriostatic mechanisms are 
both valid in terms of antimicrobial therapy36 with front lines drugs 
having one or both of these properties.  The polymers were also 
evaluated for cytotoxicity against a mammalian cell line (A549) 
(Supp. Info.). Incorporation of PPGMA comonomers slightly 
decreased cell viability relative to the PDMAEMA after 24 hours. 
However, due to the increased antimicrobial activity the PPGMA 
copolymers have a larger window of activity.  
  
Figure 3. A) SEC of P(DMAEMA(85%)-co-PPGMA(15%) copolymers. B) MIC99 
of PDMAEMA compared to P(DMAEMA(85%)-co-PPGMA(15%) copolymers. 
C-H) Fluorescence microscopy of E. coli upon exposure to varying 
concentrations of PDMAEMA and P(DMAEMA(85%)-co-PPGMA(15%)). Green 
channel shows intact membranes, red is damaged membranes.  
In summary, we have developed a rapid, scalable and simple 
approach to identify emergent antimicrobial properties of 
copolymer libraries through the use of in-air polymerization 
coupled to liquid handling robots in 96-well plates. A screening 
and selection process enabled identification of hits within a 108-
member copolymer library resulting in copolymers of 
oligo(propylene glycol) being identified with 16-fold increased 
activity compared to PDMAEMA homopolymers. Crucially, 
PPGMA was not the most hydrophobic comonomer tested, and 
non-linear relationships were observed between comonomer 





composition and activity. This material was shown to have a 
distinct mechanism of action, inhibiting bacterial growth rather 
than lysing the cell membranes. Such a material would not have 
been identified using conventional 1-vial/1-polymer methods; 
furthermore this process accelerates the discovery of new 
complex materials with emergent biological interactions.    
Experimental Section 
See the experimental section in the supporting information for 
synthetic, characterisation, microbiology and cell culture details. 
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